Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.

Wang, Zexing

Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials. [electronic resource] - Journal of chemotherapy (Florence, Italy) Aug 2016 - 328-34 p. digital

Publication Type: Journal Article; Meta-Analysis

1973-9478

10.1179/1973947815Y.0000000053 doi


Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--adverse effects
Gastrointestinal Diseases--chemically induced
Humans
Incidence
Intestinal Perforation--chemically induced
Randomized Controlled Trials as Topic
Risk
Ramucirumab